Market Forecast News

Monday, 4 September 2017

Live Cell Imaging are Good investment for Business in upcoming years

The global live cell imaging market is expected to reach USD 9.0 billion by 2025, according to a new report by Grand View Research, Inc. Rising popularity of kinetic research over fixed cellular analysis is the key driver. Addition of dyes and reagents alter the cell behavior, mostly in a negative manner, which does not showcase the natural course of action of the cellular functions. Understanding the cellular behavior in its natural state is crucial in drug discovery and targeted drug therapy. This, in turn, increases the need for live cell imaging, thus boosting the market.

In a survey by Drug Discovery World Spring, almost 21% researchers prefer & use live cell imaging and 31% plan to use it in the future. Moreover, 38% of the respondents were interested in using live cell kinetic HCS imaging in the future. The most important feature for researchers is the ability to automate the incubation and image capturing of any live cell analyzer. Secondly, they also give importance to viable cell-tracking ability of the equipment. Further development in the technology of equipment is expected to fulfill these criteria and boost the utility of the same over the forecast period.

Development in delivering probes in living cells, targeting organelles, and proteins using some of the techniques has increased use and adoption of live cell imaging in research and other applications. With improved fluorescent probes, the techniques such as Fluorescence Resonance Energy Transfer (FRET) share a majority of the share.

To request a sample copy or view summary of this report:
http://www.grandviewresearch.com/industry-analysis/live-cell-imaging-market

Further Key Findings From The Report Suggest:

Equipment dominated the product segment in 2016. The current system, although of great potential are still expected to perform better over the next few years. The general trend is to make the instruments compact and integrated for end-to-end processing.
Cell biology dominated the application with more than 30% of the shares and was closely followed by developmental biology. Stem cell and drug discovery are the upcoming fields to apply live cell imaging in the research.
North America dominated due to its high investment rate and technologically sound infrastructure. The research firms present in this region are technologically aware, hence, readily invest in high cost equipment.
Asia Pacific is expected to show fastest growth over the forecast period due to increasing application of these imaging techniques in drug discovery and personalized medicine.
Key players includes Carl Zeiss Meditec AG; Leica Microsystems; Nikon Corporation; Becton, Dickinson and Company; GE Healthcare; Olympus Corporation; Thermo Fisher Scientific Inc.; Sigma-Aldrich Corporation; PerkinElmer, Inc.; and Molecular Devices, LLC

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-live-cell-imaging-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Mixed Tocopherols Market Uplift Growth of $11.94 Billion By 2025

The global mixed tocopherols market is expected to reach USD 11.94billion by 2025, according to a new report by Grand View Research, Inc.Rising vitamin E demand in food and dietary supplements owing to rising health concerns is expected to plays a significant role in promoting the industry growth over the next few years. The global market is anticipated to observe sluggish growth at a CAGR of 2.4% from 2017 to 2025.

Alpha rich tocopherols was the leading product segment and is anticipated to grow at a CAGR of 2.3%, by revenue, over the forecast period. The segment is expected to gain share over the forecast period owing to high demand in dietary supplements. Health benefits associated with vitamin E to treat deficiency and diseases such as lung, oral, colorectal and pancreatic cancer; polyps, and gastric are also anticipated to drive the mixed tocopherols market in pharmaceuticals over the forecast period.

To request a sample copy or view summary of this report:
http://www.grandviewresearch.com/industry-analysis/mixed-tocopherols-industry

Further key findings from the report suggest:

The global mixed tocopherols demand was117.8 kilo tons in 2016 and is estimated to grow at a CAGR of 3.6% from 2017 to 2025
Mixed tocopherols demand in dietary supplements was 50.9 kilo tons in 2016 and is anticipated to witness moderate growth over the next eight years
Product demand in animal feed nutritionis anticipated to emerge as the fastest growing application segment, and generate revenues worth over USD 2 billion by 2025
Mixed tocopherolsindustry valuation in North America is projected to reach USD 3.60 billion by 2025 and is estimated to grow as a significant rate from 2017 to 2025
The U.S. gamma rich tocopherols demand is anticipated to emerge as the fastest growing market in North America and is expected to reach total volume of over 5.6 kilo tons by 2025
The industry in Europeis projected to witness moderate growth of 2.9% from 2017 to 2025 owing to the increased use of mixed tocopherols as antioxidants and feed additives
Asia Pacific was the dominant consumer in 2016. High rate of dietary supplements, animal feed, and pharmaceuticals manufacturing in key economies including China, Japan, and India is the major factor for industry penetration.
Key industry participants such asBASF, DSM, ADM,and Cargill dominated the global mixed tocopherol market over the next few years. The major players operating in the mixed tocopherol market comprise, BTSA, Vitae Naturals, Zhejiang Medicine Co., Ltd. (ZMC), COFCO Tech Bioengineering Co., Ltd., Eisai Food & Chemical Co., Ltd., and Vance Group Ltd.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-mixed-tocopherols-market

About Grand View Research

For More Information: www.grandviewresearch.com

Sunday, 3 September 2017

Rapid Increase in Narcolepsy Therapeutics Market - Key Factors, Market Segments Regions and Industry Forecasts Analysis to 2025

The global narcolepsy therapeutics market is expected to reach USD 3.85 billion by 2025, according to a new report by Grand View Research, Inc. The increasing awareness about this sleep disorder among public and healthcare providers is a key factor contributing to the market growth.

The Narcolepsy Network has estimated that out of every 2,000 people 1 is afflicted by this condition. Moreover, Narcolepsy UK states that around 25% patients are identified and remaining 75% are untreated as they remain undiagnosed or are misdiagnosed, which is alarming. Some organizations and networks are constantly working to spread awareness about this condition among the patients and physicians.

To request a sample copy or view summary of this report:
http://www.grandviewresearch.com/industry-analysis/narcolepsy-therapeutics-market

Further key findings from the report suggest:

The narcolepsy therapeutics market is expected to grow substantially owing to the worldwide increasing incidence of this disorder.
Narcolepsy with cataplexy was identified as the largest type segment in 2016. It is expected to retain its position throughout the forecast period owing to the rising cases of cataplexy in patients suffering from narcolepsy.
Narcolepsy without cataplexy is likely to witness the fastest growth over the forecast period due to increasing awareness about Excessive Daytime Sleepiness (EDS) through various mediums, such as awareness campaigns
Sodium oxybate dominated the product segment in terms of revenue share in the year 2016, and it is also expected to be the fastest growing segment over the forecast period. Drugs belonging to this class have higher costs and favorable coverage policies.
Xyrem is the only FDA-approved drug in this category and is extensively prescribed for the treatment of cataplexy and EDS. American Academy of Sleep Medicine (ASSM) recommends it as a standard treatment of this disorder.
Europe dominated the regional market in terms of revenue share in 2016 because of increase in capital investments and existence of established healthcare infrastructure along with a large target population
The H1N1 influenza postvaccination pandemic of the year 2009 has resulted in growth of number of narcolepsy patients
Asia Pacific is likely to exhibit fastest growth during the forecast period due to the rising healthcare expenditure in this region, rising awareness among people, highest prevalence in Japan, and presence of emerging economies such as China & India
Some of the major market players are Jazz Pharmaceuticals PLC;Teva Pharmaceutical Industries Ltd.;Graymark Healthcare, Inc.;Addrenex Pharmaceuticals, Inc.; and BIOPROJET.
Mergers and acquisitions are strategic initiatives undertaken by these market players in an attempt to remain competitive. In addition, companies are expanding their geographical presence to untapped markets.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-narcolepsy-therapeutics-market

About Grand View Research

For More Information: www.grandviewresearch.com

U.S. Food Container Market is Growing at CAGR of 3.4% By 2025

The U.S. food container market is projected to reach USD 51.92 billion by 2025, according to a new report conducted by Grand View Research, Inc. Rising expenditure towards improving nutritional supplementation by gym professionals and athlete is expected to promote the usage of milk and whey ingredients in the formulation sports nutrition goods. In addition, product innovation in baby care products including infant milk formula by Unilever and Nestle in the U.S. is expected to upscale the requirements of containers as packaging medium for milk powder and whey ingredients over the forecast period.

Meat processed goods are projected to grow at a CAGR of 4.7% from 2016 to 2025. High prevalence of production sites of meat processing companies including Tyson Foods, JBF, Cargill and National Beef is projected to keep extensive market reach for packaging products over the next nine years.

To request a sample copy or view summary of this report:
http://www.grandviewresearch.com/industry-analysis/us-food-container-market

Further key findings from the report suggest:

U.S. food container industry is expected to reach USD 51.92 billion by the end of 2025, expanding at a CAGR of 3.4% from 2016 to 2025. Product innovation by convenience food manufacturers is expected to remain a key driving force in the near future.
Flexible packaging is expected to foresee revenue growth at a CAGR of 4.0% from 2016 to 2025. Shifting inclination from conventional glass and metal to lightweight polymers including polyethylene (PE) and polyvinyl diene chloride (PVC) as a raw material for packaging of food items is expected to be a favorable factor.
Paperboard market was valued at USD 7.69 billion in 2015. The product is expected to foresee significant gains in packaging dry goods including chips, sausages, burgers and sandwiches.
Bakery products are projected to account for 17.8% of global market share by the end of 2025. Increment in sales of Pizza Crusts, Cakes & Pastries as a result of product innovation by bakery processing companies including Group Bimbo is expected to expand the scope of packaging.
Key vendors include Berry Plastics, Bemis, Silgan Holdings, Amcor, Ball Corporation, Ardagh Group, Sealed Air Corporation, and Graham Packaging. In October 2013, Silgan Holdings Inc. completed the acquisition of leading plastic closure manufacturer, Portola Packaging, Inc., for approximately USD 265 million. This acquisition is expected to result in increasing the availability of plastic closures for the captive production of containers used in the food & beverage industry.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/us-food-container-market-analysis

About Grand View Research

For More Information: www.grandviewresearch.com

Aerosol Valves Market Growth - Rising Demand for Aerosol Based Household Cleaners

The global aerosol valves market is expected to reach USD 1.87 billion by 2025, growing at a CAGR of 5.5%, according to a new report by Grand View Research, Inc. Rising demand for aerosol based household cleaners is expected to emerge as a major factor driving growth. In addition, growth in the demand for easy to use products due to widening consumer acceptance is likely to drive growth.

The raw materials required for the product manufacture such as springs, dip tubes, and coatings are procured from low cost suppliers. The industry witnesses the production of highly customized products with the specifications varying with the can design. In addition, the wide availability of raw materials results in a diminished supplier power for the manufacturers.

The industry is characterized by the presence of stringent regulations by agencies, pertaining to the raw material grades and coatings used in the valve systems. However, the industry is expected to witness limited regulations, primarily in Asia Pacific, thereby realizing high growth.

Introduction of innovative products by key FMCG manufacturers such as P&G and Unilever in high potential markets including China and India in light of expansion of the domestic retail markets is expected to promote the usage of such products. This trend is expected to expand the market size over the forecast period.

To request a sample copy or view summary of this report:
http://www.grandviewresearch.com/industry-analysis/aerosol-valve-market

Further key findings from the report suggest:

The demand for aerosol valves for personal care products accounted for 35.8% of the consumption volume in 2016, driven by rising sales of products such as deodorants, hairsprays and shaving creams
The demand for continuous valves in household segment is expected to register a CAGR of 4.9% by revenue from 2017 to 2025 due to heightened product consumption envisaged by limited human interaction with aerosol cleaners
The demand other valves including bag-on-valves in the food segment is likely to register a CAGR of 5.8% from 2017 to 2025 due to superior product performance for dispensing food products
The market in North America accounted for a consumption of 4,682.8 million valves due to high aerosol production in the U.S. The industry is expected to grow in the wake of high adoption levels coupled with increasing penetration levels
China is estimated to account for an industry revenue of USD 102.4 million in 2016, on account of low cost production coupled with superior economies of scales achieved by the manufacturers in the economy
Key players including Mitani Valve and Coster Group lay high emphasis on capacity increases in order to gain market share and increase the company revenues

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-aerosol-valve-market

About Grand View Research

For More Information: www.grandviewresearch.com